Regeneron (REGN) PRALUENT Briefing Docs Positive But Risk to Labeling for Statin Intolerance, BMO Capital Says
Go back to Regeneron (REGN) PRALUENT Briefing Docs Positive But Risk to Labeling for Statin Intolerance, BMO Capital Says| Regeneron (NASDAQ: REGN) | Delayed: 612.50 +2.56 (0.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $609.94 | 52 Week High | $592.36 | |||
| Open | $604.46 | 52 Week Low | $325.35 | |||
| Day High | $613.56 | P/E | 160.76 | |||
| Day Low | $594.90 | EPS | $3.81 | |||
| Volume | 1,604,280 | |||||

